Literature DB >> 7099070

Trigeminal neuralgia and hemifacial spasm: treatment by microvascular decompression.

R G Rushworth, S F Smith.   

Abstract

On the basis of observation of 26 patients, we consider that the common cause in trigeminal neuralgia and hemifacial spasm is compression of the nerve-root entry zone at the brainstem by a blood vessel, usually an artery. By mobilising the vessel, and securing it away from the nerve, symptoms were relieved in 16 of 17 patients with trigeminal neuralgia and in seven of nine patients with hemifacial spasm for a follow-up period of up to four years. Trigeminal microvascular decompression had few complications, but three patients treated for facial hemispasm had postoperative deafness and one had a probable small brainstem infarct. The major advantage of this surgical approach is that is possible to relieve the symptoms without facial anaesthesia or paralysis.

Entities:  

Mesh:

Year:  1982        PMID: 7099070     DOI: 10.5694/j.1326-5377.1982.tb132398.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

Review 1.  The cranial nerve vascular compression syndrome: I. A review of treatment.

Authors:  A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 2.  Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

Authors:  Matthew Bartindale; Matthew Kircher; William Adams; Neelam Balasubramanian; Jeffrey Liles; Jason Bell; John Leonetti
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-12       Impact factor: 3.497

3.  Hemifacial spasm: 20-year surgical experience, lesson learned.

Authors:  Hector Soriano-Baron; Olivia Vales-Hidalgo; Emiliano Arvizu-Saldana; Sergio Moreno-Jimenez; Rogelio Revuelta-Gutierrez
Journal:  Surg Neurol Int       Date:  2015-05-20

4.  Cardinal features of superior oblique myokymia: An infrared oculography study.

Authors:  Sumeer Thinda; Yi-Ren Chen; Yaping Joyce Liao
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.